Merckx index said:
...
I looked at that post, and it doesn’t seem to me that Hagerman is implicated in possible blood doping.
if he were implicated in such practices, why would he be explicit about it in his publications? Go look through the academic output of Geert Leinders for instance. Good luck finding any kind of hint in there to blood doping, or references to Ekblom/Gerschler/Astrand, or suggestions for future cardiorespiratory research on adolescents with the aim of identifying outstanding Olympic athletes.
As you yourself admit, his study of cardiorespiratory conditioning is not by itself suspicious.
'suspicious' or not, matter of taste I guess.
The whole way in which he speaks about identifying outstanding athletes among adolescents, then the references to Gerschler and the Scandinavian bunch. In an era where there is a strong politically driven campaign in American sports aimed at closing the gap with the bloc-countries. It just screams junior doping, imo.
And while it may not be suspicious to you, it's still more suspicious than anything a Geert Leinders, a Ferrari, a Testa, or a Del Moral has ever put in print to my knowledge.
You attempt to find something sinister in his work by noting he cited Ekblom, who did a transfusion study.
You're forgetting what the null hypothesis is.
The null hypothesis, i.e. the hypothesis that imposes itself even in the absence of any kind of contextual evidence, is that Lemond, Heiden and other US athletes who were successful at the time, were using the same stuff (or better) as their non-US competitors. That should be the common sense starting point of the discussion, at least to those versed in the history of doping in cycling and prosport.
All the stuff uncovered on these pages (not just by me) does nothing more, and nothing less, than showing that all the means and know-how was there. So while it would be 'nice' to find something really sinister, it's not necessary for the null hypothesis to remain (or even gain) plausibility in light of Hagerman's and Costill's publication record.
So no, it's not necessary to 'prove' that Hagerman was a blood doper.
Showing that he had the know-how and connections is enough, for now.
So no, there is no need to find photographic evidence of Hagerman sticking a needle in Lemond's arm for that hypothesis to make sense.
But in the first place, the fact that he cites someone whose work includes a transfusion study does not by itself imply that Hagerman was interested in transfusing athletes; Hagerman’s reference to Ekblom does not specifically mention transfusion. In the second place, Ekblom did a lot of work on the cardiorespiratory system, and as far as I can tell, transfusion was just one tool that he found useful. E.g., he also studied the effect of CO, which obviously does not enhance performance.
agreed on all accounts.
And much later in his career, he helped develop a blood passport type of approach to detect blood manipulation—
Yes. But you'll agree that hat doesn't exonerate him of anything. To give one (of many) examples: Freiburg's Yorck Schumacher was also part of the UCI's passport committee.
work foreshadowed by his statement against doping in that NYT article you linked.
Not really. Such statements are rife from all dopers and facilitators in all periods of time and across all sports. Such blanket statements foreshadow little, I'm afraid. In fact, I would argue that Hagerman's publication record (including altiutude research for the US Army in the 60s), and his proposals for future research, combined with him being recruited by Dardik, foreshadows a thing or two.
None of this proves that Ekblom was not interested in transfusing athletes to increase their performance, but I don’t find his work to be much in the way of evidence of that, other than that he was clearly aware of the potential.
Sure, though I personally know too little about him and his work to be able to comment on that in any detail. As I said earlier, it would be great to have a separate thread looking into the history of blood doping for athletic purposes. The main point wrt the references to Ekblom, Astrand, Saltin and Gerschler is that it shows that, already in the mid-70s, Hagerman and Costill were well aware of their works and, thus, most likely, aware of the existence (and benefits) of certain blood boosting techniques. (Hagerman's work for the US army in the 60s is further evidence of that.)
Now, Hagerman and Costill being aware of those techniques in the mid-70s is not a trivial fact. In 1984, when Ed Burke was exposed as one of the architects of the 84 BB program, he claimed he only learned about the technique in 1983 reading about it in some German journal. I think you'll agree that that was probably a lie. I think it was part of a larger white-wash, the purpose of which was to downplay the whole thing. The Van Haute case is further evidence of that.
None of this proves that Ekblom was not interested in transfusing athletes to increase their performance, but I don’t find his work to be much in the way of evidence of that, other than that he was clearly aware of the potential. To contrast him with Ariel, the latter appeared to be keenly interested, at least at one point in his career, in the performance enhancing effects of steroids, whereas Ekblom appeared to regard performance enhancement by blood transfusion as just one approach to understanding the role of the cardiorespiratory system in optimal performance. Also, of course, Ariel was directly involved with the OTC, whereas Ekblom wasn’t.
agreed. Wrt Ariel, his interest in the effects of steroids is not limited to "at one point in his carreer". Rather, in addition to his articles from 1972, he explicitly (re)stated said interest in interviews in 1977 which I've linked to earlier.
While I’m on the subject of Ariel, I want to make a couple of points that might reduce, though certainly not eliminate, the suspicion surrounding him. First, as I noted in my previous post, he apparently stopped all his studies of steroids well before the OTC was founded. So if he was actually giving athletes these substances and determining their PE effects at this time, he wasn’t publishing the results. I suppose one could argue that given that they were banned substances, he might well be reluctant to do so. But in any case, there is no evidence I’m aware of that he was studying steroids at this time.
Second, given his deep interest in maximizing biomechanical efficiency, it’s possible he wanted to see how this was affected by steroids (I haven’t read any of his papers, so I’m just speculating here). Perhaps he was guided by the thought that steroids improved performance in part by improving the efficiency of movement (as a result of or independently of the increase in muscle size and strength), giving him some goal to shoot for in undoped athletes.
I would probably agree with your formulations here. It's possible. But not likely.
And no, no evidence of him *studying* it, but the interviews from 1977 quite explicitly underline his interest in the topic.
Finally, in that earlier post, you repeat the claim that Hagerman was testing the effects of steroids on adolescents.
i said that once, was corrected by djpbaltimore, thanked him for it, and acknowledged it.
to my knowledge i never repeated it. And I went on to check it myself (through references in other literature), and learned it was on (adult) weightlifters. I posted that up, too.
His cardiorespiratory study with the references to ekblom, astrand and gerschler and the whole bunch was on adolescents. Whether the (olympic) pentathletes he interviewed in the 60s in relation to steroids included adolescents remains to be seen.
As I noted before, his only study of steroids I’m aware of appeared to focus on parameters unrelated to performance enhancement. I understand Baltimore is going to send you a copy.
Not sure, but note in any case that for weightlifters (and similar power disciplines) imo there's no clear distinction between studying performance enhancement and studying other physical/physiological effects of steroids (such as weight/bodymass increase). In such disciplines weight/bodymass increase is always going to correlate with performance.